Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass

This publication has 22 references indexed in Scilit:

• Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation
  The Journal of Thoracic and Cardiovascular Surgery, 2001
• Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass
  Clinical and Experimental Immunology, 2001
• Interleukin-1, interleukin-6 and myocardial enzyme response after coronary artery bypass grafting – a prospective randomized comparison of the conventional and three minimally invasive surgical techniques✩
  European Journal of Cardio-Thoracic Surgery, 2000
• Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent
  The Journal of Thoracic and Cardiovascular Surgery, 1998
• Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass
  Journal of Cardiothoracic and Vascular Anesthesia, 1997
• Prevention of the hypoxic reoxygenation injury with the use of a leukocyte-depleting filter
  The Journal of Thoracic and Cardiovascular Surgery, 1997
• Endothelial Cell Injury in Cardiovascular Surgery: The Systemic Inflammatory Response1
  The Annals of Thoracic Surgery, 1997
• Systemic inflammatory response syndrome after cardiac operations
  The Annals of Thoracic Surgery, 1996